The European CLL Association (ECLLA) is pleased to announce the release of the May 2026 edition of the ECLLA Newsletter.
This edition highlights some of the key milestones, activities, and developments from ECLLA’s first months of activity, including the growth of the organisation’s European membership network, the establishment of the ECLLA Medical Advisory Board, participation in the European Hematology Association (EHA) Patient Advocacy Committee, and the successful ECLLA European Policy Roundtable held in Dublin.
The newsletter also features upcoming initiatives, including the ECLLA Breakfast Panel taking place alongside EHA 2026 in Stockholm, focused on the holistic impact of treatment-free periods in Chronic Lymphocytic Leukemia (CLL).
As ECLLA continues to grow, the newsletter aims to keep members, partners, healthcare professionals, patient advocates, researchers, and stakeholders informed about ongoing activities, collaborations, and opportunities to strengthen the European CLL community.
📩 Read the May 2026 ECLLA Newsletter here:
https://mailchi.mp/28342a419e6b/european-cll-association-eclla-newsletter-may-2026?e=5b0b951c20
We thank all members, collaborators, partners, and supporters for being part of ECLLA’s journey and helping strengthen collaboration across geographic Europe.
#ECLLA #CLL #OneEuropeEqualCare